embecta to Report Fiscal Second Quarter 2023 Financial Results

Rhea-AI Summary

Embecta Corp. (Nasdaq: EMBC), a leading diabetes care company, announced an upcoming conference call to discuss its fiscal second quarter 2023 results on May 12, 2023, at 8:00 a.m. ET. The call will cover financial results, operational updates, and include a Q&A session. Interested parties can access the live webcast through the company's investor relations website or via teleconference. A replay of the call will be available later that day and archived for one year.

With a legacy of nearly 100 years in insulin delivery and a dedicated workforce of approximately 2,000 employees, Embecta aims to empower individuals with diabetes through innovative solutions.

Positive

• Embecta's extensive experience in insulin delivery spans nearly 100 years.
• The company emphasizes innovation in diabetes care solutions.

Negative

• None.

PARSIPPANY, N.J., April 20, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, will host a conference call to discuss its fiscal second quarter 2023 financial results, provide an operational update, and host a question and answer session, at 8:00 a.m. Eastern Time (ET) on Friday, May 12, 2023.

Those who would like to participate may access the live webcast here, or access the teleconference here. The live webcast can also be accessed via the company’s website at investors.embecta.com.

A webcast replay of the call will be available beginning at 11:00 a.m. ET on May 12, 2023, via the embecta investor relations website and archived on the website for one year.

About embecta 
embecta is one of the largest pure-play diabetes care companies in the world, leveraging its nearly 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships and the passion of approximately 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, Instagram and Twitter.

Contacts:
Media Christian Glazar Sr. Director, Corporate Communications 908-821-6922 Contact Media Relations	Investors Pravesh Khandelwal VP, Head of Investor Relations 551-264-6547 Contact IR

FAQ

When is Embecta's fiscal second quarter 2023 financial results call?

Embecta's fiscal second quarter 2023 financial results call is scheduled for May 12, 2023, at 8:00 a.m. ET.

How can I access the Embecta conference call?

You can access the Embecta conference call via the live webcast on their investor relations website or through a teleconference link provided in their announcement.

Will there be a replay of Embecta's financial results call?

Yes, a replay of Embecta's financial results call will be available starting at 11:00 a.m. ET on May 12, 2023, and archived for one year.

What is Embecta's focus in diabetes care?

Embecta focuses on empowering people with diabetes through innovative solutions and a long-standing legacy in insulin delivery.